Success stories
Hemofarm
— production of finished pharmaceutical products
₽ 778 mln
investment
Germany
country
Obninsk
city
May 2006
Hemofarm plant is launched
2007
Hemofarm obtained Certificate of GMP Compliance, which allows the company to export pharmaceutical products to the countries of the European Union.
“Decision was made to build Distribution Center of STADA CIS, first and unique in Russia. Also, we work on the project to create pilot research center in Obninsk”.
Verolub Lubinkovich, Director General of Hemofarm
Hemofarm Company is a part of German STADA Arzneimittel AG Group of companies, being one of the major manufacturers of generics in Europe and worldwide.
The company is headquartered in Bad Vilbel (Germany).
200 jobs were created, volume of investments is RUR 778 mln.
Hemofarm LLC (STADA CIS Group), project to build full-cycle production plant for solid pharmaceutical products. Today, Hemofarm plant in Obninsk is one of the most modern pharmaceutical production facilities in Russia certified for GMP compliance. Currently, the plant manufactures the following solid pharmaceutical products — Indapamide, Enalapril, Enzix, Enzix Duo. Production capacity of the plant is 80 mln packs per year. Surface of production facilities — 12,300 m2. STADA CIS – Russia is number two in sales volume at international markets, at which STADA is present.
Thanks to this project the region resolved the issue of permanent presence of qualitative and cheap drugs at Kaluga pharmacies and hospitals. In 2014 STADA made decision to build its first Russian distribution center.
Company information
Hemofarm LLC (STADA CIS Group), project to build full-cycle production plant for solid pharmaceutical products. Today, Hemofarm plant in Obninsk is one of the most modern pharmaceutical production facilities in Russia certified for GMP compliance. Currently, the plant manufactures the following solid pharmaceutical products — Indapamide, Enalapril, Enzix, Enzix Duo. Production capacity of the plant is 80 mln packs per year. Surface of production facilities — 12, 300 m2. STADA CIS – Russia is number two in sales volume at international markets, at which STADA is present.
Thanks to this project the region resolved the issue of permanent presence of qualitative and cheap drugs at Kaluga pharmacies and hospitals. In 2014 STADA made decision to build its first Russian distribution center.
STADA AG has 14 production sites and 29 representations worldwide. Majority of them are located in South-Eastern Europe – three in Serbia, one in Montenegro, one in Bosnia, one in the UK, two – in Russia, Obninsk and Nizhny Novgorod, three in Vietnam and one in China. Among these 14 sites, 12 sites, including the one in Obninsk, have international GMP Certificate (Good Manufacturing Practices), which allow shipping products to all European countries.
Production placement application
Establishment of industrial parks with high quality sites with all relevant utilities for new plants construction ensures well-balanced distribution of industrial facilities throughout the region with due consideration of transport, utilities and social infrastructure development and future labor resources development.
If you are interested in placement of a production facility at an investment site, please fill in the online application form.
Thank you!
You successfully subscribed to news digest
Thank you!
Your message has been sent.
error
Error!